RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

Authors
Category Primary study
JournalINFLAMMATORY BOWEL DISEASES
Year 2022
This article has no abstract
Epistemonikos ID: 332a468e75f9c69bba42eec907cabf3c36d44479
First added on: Feb 13, 2025